International Stem Cell (ISCO) Current Assets (2010 - 2026)

International Stem Cell (ISCO) has reported Current Assets for 17 consecutive years, with $3.9 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Current Assets rose 2.08% year-over-year to $3.9 million in Q2 2026; TTM through Jun 2026 was $3.9 million, a 2.08% increase from a year earlier, with the FY2025 full-year figure at $3.4 million, down 4.19% from the prior year.
• Current Assets was $3.9 million for Q2 2026 at International Stem Cell, up from $3.4 million in the prior quarter.
• Over five years, Current Assets peaked at $3.9 million in Q2 2026 and troughed at $2.7 million in Q3 2022.
• A 5-year average of $3.5 million and a median of $3.6 million in 2024 frame the typical range for Current Assets.
• Across the five-year window, Current Assets surged 35.48% in 2023 and slipped 4.59% in 2024, its largest moves.
• Over 5 years, Current Assets stood at $3.0 million in 2022, then advanced by 18.83% to $3.5 million in 2023, then grew by 1.11% to $3.6 million in 2024, then dropped by 4.19% to $3.4 million in 2025, then rose by 14.92% to $3.9 million in 2026.
• The last three Current Assets figures came in at $3.9 million (Q2 2026), $3.4 million (Q4 2025), and $3.7 million (Q3 2025), per Business Quant data.